Cafepharma Today

April 17 2025 - Lilly soars after weight-loss pill results rival Ozempic’s
Lilly soars after weight-loss pill results rival Ozempic’s
CDC panel backs broader use of RSV shots
Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology
Trump throws pharma 'bread crumb' concession with call to end IRA pill penalty
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genentech, OSI Pharmaceuticals report positive Phase III cancer study results
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:30pm
tags:
Daiichi Sankyo completes purchase of stake in Ranbaxy
Pharmaceutical Business Review
Saturday, November 8, 2008 - 12:28pm
tags:
ETHEX Corporation Initiated Nationwide Voluntary Recalls of Specific Lots of Five Generic Products Due to the Potential for Oversized Tablets
MarketWatch
Saturday, November 8, 2008 - 12:27pm
tags:
Do medication top-up fees mean the end of the NHS?
Times Online, UK
Saturday, November 8, 2008 - 12:26pm
tags:
Breakthrough jab to halt Alzheimer's disease is tested on patients
Daily Mail, UK
Saturday, November 8, 2008 - 12:24pm
tags:
http://www.fool.com/investing/small-cap/2008/11/07/inventiv-reinvents-growth.aspx
The Street
Saturday, November 8, 2008 - 12:07pm
tags:
inVentiv Reinvents Growth
Motley Fool
Saturday, November 8, 2008 - 12:04pm
tags:
Amgen Eyes Internet and Modest Sales Force to Launch Denosumab
Wall Street Journal
Saturday, November 8, 2008 - 12:02pm
tags:
Teva's Steady Growth
The Motley Fool
Saturday, November 8, 2008 - 11:57am
tags:
Thinning Out the Pipeline
Motley Fool
Saturday, November 8, 2008 - 11:56am
tags:
Drug stocks gain despite gloomy jobs report
MarketWatch
Saturday, November 8, 2008 - 11:54am
tags:
Amgen expects newer drugs to offset weak Aranesp sales
MarketWatch
Saturday, November 8, 2008 - 11:54am
tags:
Pharmacopeia to Request a Hearing With NASDAQ Following Receipt of Notice of Non-Compliance
Yahoo
Saturday, November 8, 2008 - 11:52am
tags:
ZymoGenetics rises following analyst upgrade
Yahoo/AP
Saturday, November 8, 2008 - 11:49am
tags:
Onyx -- Still Waiting
Motley Fool
Saturday, November 8, 2008 - 11:49am
tags:
OSI and Genentech say Tarceva increased progression-free survival in lung cancer trial
Yahoo/AP
Friday, November 7, 2008 - 12:33pm
tags:
Dendreon At The Mercy Of Provenge
Forbes
Friday, November 7, 2008 - 12:33pm
tags:
"Boning Up" On Amgen's D-mab
CNBC
Friday, November 7, 2008 - 12:32pm
tags:
Nektar Therapeutics' 3rd-quarter loss widens on continued revenue drop
Yahoo/AP
Friday, November 7, 2008 - 12:31pm
tags:
WuXi Pharma announces three-year deal with Pfizer
Yahoo/AP
Friday, November 7, 2008 - 12:30pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Proton Pump Inhibitors Do More Than You Think
In the Pipeline
Entropy, Enthalpy, and Hydrophobicity
In the Pipeline
The Continuing Crisis, Part XII: Behold RFK Jr.'s FDA
In the Pipeline
RNA Motifs Coming Into Focus
In the Pipeline
Pharmaceutical Tariffs: The What and the How
In the Pipeline
Metallic Flatland
In the Pipeline
The Continuing Crisis, Part XI: Feral Children, Breaking Things
In the Pipeline
Methyl Groups Will Always Be Magic
In the Pipeline
Predicting Picky Protein Interactions
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.